Market Share of Europe Cancer Therapeutics Industry
The Europe cancer therapeutics market is fragmented in nature due to the presence of fewer companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, and Pfizer Inc.
Europe Cancer Therapeutics Market Leaders
Amgen Inc.
AstraZeneca PLC
Bayer AG
Bristol-Meyrs Squibb Company
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
